ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide)

2007-02-01  

Identity

HGNC
LOCATION
4q23
LOCUSID
ALIAS
ADH-3,ADHX,AMEDS,BMFS7,FALDH,FDH,GSH-FDH,GSNOR,HEL-S-60p
FUSION GENES

Other Information

Locus ID:

NCBI: 128
MIM: 103710
HGNC: 253
Ensembl: ENSG00000197894

Variants:

dbSNP: 128
ClinVar: 128
TCGA: ENSG00000197894
COSMIC: ADH5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197894ENST00000296412P11766
ENSG00000197894ENST00000296412Q6IRT1
ENSG00000197894ENST00000502590D6R9G2
ENSG00000197894ENST00000503130H0YAG8
ENSG00000197894ENST00000505652D6RFE4
ENSG00000197894ENST00000512659D6RAY0
ENSG00000197894ENST00000626055D6RAY0

Expression (GTEx)

0
50
100
150
200
250

Pathways

PathwaySourceExternal ID
Glycolysis / GluconeogenesisKEGGko00010
Fatty acid degradationKEGGko00071
Tyrosine metabolismKEGGko00350
Retinol metabolismKEGGko00830
Metabolism of xenobiotics by cytochrome P450KEGGko00980
Drug metabolism - cytochrome P450KEGGko00982
Glycolysis / GluconeogenesisKEGGhsa00010
Fatty acid degradationKEGGhsa00071
Tyrosine metabolismKEGGhsa00350
Retinol metabolismKEGGhsa00830
Metabolism of xenobiotics by cytochrome P450KEGGhsa00980
Drug metabolism - cytochrome P450KEGGhsa00982
Metabolic pathwaysKEGGhsa01100
Chemical carcinogenesisKEGGhsa05204
Chemical carcinogenesisKEGGko05204
Carbon metabolismKEGGhsa01200
Carbon metabolismKEGGko01200
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase 1 - Functionalization of compoundsREACTOMER-HSA-211945
Ethanol oxidationREACTOMER-HSA-71384

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
366567162023GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.1
376159252023Effects of the major formaldehyde catalyzer ADH5 on phenotypes of fanconi anemia zebrafish model.0
366567162023GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.1
376159252023Effects of the major formaldehyde catalyzer ADH5 on phenotypes of fanconi anemia zebrafish model.0
335124382021Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.10
342190792021[Aldehyde degradation deficiency (ADD) syndrome: discovery of a novel fanconi anemia-like inherited BMF syndrome due to combined ADH5/ALDH2 deficiency].1
335124382021Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.10
342190792021[Aldehyde degradation deficiency (ADD) syndrome: discovery of a novel fanconi anemia-like inherited BMF syndrome due to combined ADH5/ALDH2 deficiency].1
321128812020Mitophagy contributes to alpha-tocopheryl succinate toxicity in GSNOR-deficient hepatocellular carcinoma.6
331474382020Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.47
321128812020Mitophagy contributes to alpha-tocopheryl succinate toxicity in GSNOR-deficient hepatocellular carcinoma.6
331474382020Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.47
310435862019nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis.5
310435862019nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis.5
290745972018S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy.33

Citation

Dessen P

ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43755/adh5-(alcohol-dehydrogenase-5-(class-iii)-chi-polypeptide)